10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?-Reference-Cited by-同舟云学术

10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?

Published:2023-05-30 Issue:5 Volume:21 Page:751-759
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Büssgen Melanie^ORCID,Stargardt Tom

Funder

Universität Hamburg

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40258-023-00815-7.pdf

Reference44 articles.

1. IQVIA Deutschland. https://www.iqvia.com/locations/germany (Accessed 9 Feb 2021).

2. AMNOG—Nutzenbewertung von Arzneimitteln gemäß § 35a SGB V—Gemeinsamer Bundesausschuss. https://www.g-ba.de/themen/arzneimittel/arzneimittel-richtlinie-anlagen/nutzenbewertung-35a/ (Accessed 1 Feb 2021).

3. Paris V, Belloni A. Value in pharmaceutical pricing; 2013. https://doi.org/10.1787/5k43jc9v6knx-en.

4. World Health Organization. Regional Office for Europe, European Observatory on Health Systems and Policies, Busse, Reinhard and Blümel, Miriam. Germany: health system review; 2014. https://apps.who.int/iris/handle/10665/130246 (Accessed 9 Oct 2022).

5. Reckers-Droog V, van Exel J, Brouwer W. Willingness to pay for health-related quality of life gains in relation to disease severity and the age of patients. Value Health. 2021;24(8):1182–92. https://doi.org/10.1016/j.jval.2021.01.012.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”;Applied Health Economics and Health Policy;2023-12-02

2. Authors’ Reply to Gandjour: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?”;Applied Health Economics and Health Policy;2023-12-02